Sfoglia per AUTORE
COPPA J
Collezione AOU San Luigi di Orbassano

  

Items : 3

Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial. in BMC cancer / BMC Cancer. 2023 Sep 26;23(1):908. doi: 10.1186/s12885-023-11287-2.

2023
AOU San Luigi di Orbassano

Corti F; Brizzi MP; Amoroso V; Giuffrida D; Panzuto F; Campana D; Prinzi N; Milione M; Cascella T; Spreafico C; Randon G; Oldani S; Leporati R; Scotto G; Pulice I; Stocchetti BL; Porcu L; Coppa J; Di Bartolomeo M; de Braud F; Pusceddu S;

Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors. in JAMA network open / JAMA Netw Open. 2022 Feb 1;5(2):e220290. doi: 10.1001/jamanetworkopen.2022.0290.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Modica R; Andreasi V; Spada F; Severi S; Bracigliano A; Ambrosio MR; Zanata I; Puliafito I; Lamberti G; Cingarlini S; Rocca PA; Pignata SA; Rinzivillo M; Persano I; Versari A; Bongiovanni A; Lastoria S; Maccauro M; Seregni E; Di Maio M; Porcu L; Giacomelli L; Ricci C; Corti F; Perfetti V; Cirillo F; Grimaldi F; Cives M; Bajetta E; et alii...

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors. in Endocrine-related cancer / Endocr Relat Cancer. 2018 Jun;25(6):607-618. doi: 10.1530/ERC-17-0489. Epub 2018 Mar 20.

2018
AOU San Luigi di Orbassano

Pusceddu S; Barretta F; Trama A; Botta L; Milione M; Buzzoni R; De Braud F; Mazzaferro V; Pastorino U; Seregni E; Mariani L; Gatta G; Di Bartolomeo M; Femia D; Prinzi N; Coppa J; Panzuto F; Antonuzzo L; Bajetta E; Brizzi MP; Campana D; Catena L; Comber H; Dwane F; Fazio N; Faggiano A; Giuffrida D; Henau K; Ibrahim T; et alii...